Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dagmar Jürgens

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cell Biology International|February 16, 2002
Production and characterization of Escherichia coli enterohemolysin and its effects on the structure of erythrocyte membranesDagmar Jürgens, Muhsin Ozel, Ntondo B Takaisi-Kikuni
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentDieter Willbold, Janine Kutzsche, Nicoleta Carmen Cosma, et al.
Molecules (Basel, Switzerland)|October 11, 2017
Large-Scale Oral Treatment Study with the Four Most Promising D3-Derivatives for the Treatment of Alzheimer's DiseaseJanine Kutzsche, Sarah Schemmert, Markus Tusche, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 27, 2020
Safety and pharmacokinetics of the orally available antiprionic compound PRI-002: A single and multiple ascending dose phase I studyJanine Kutzsche, Dagmar Jürgens, Antje Willuweit, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentDagmar Jürgens, Gerhard Tischler, Alexander Brener, et al.
British Journal of Pharmacology|December 29, 2023
An orally available Ca<sub>v</sub>2.2 calcium channel inhibitor for the treatment of neuropathic painJanine Kutzsche, Gustavo A Guzman, Antje Willuweit, et al.
Scientific Reports|November 28, 2017
The Aβ oligomer eliminating D-enantiomeric peptide RD2 improves cognition without changing plaque pathologyThomas van Groen, Sarah Schemmert, Oleksandr Brener, et al.
Neuropeptides|December 24, 2017
Aβ oligomer eliminating compounds interfere successfully with pEAβ(3-42) induced motor neurodegenerative phenotype in transgenic miceTina Dunkelmann, Kerstin Teichmann, Tamar Ziehm, et al.
Heliyon|August 23, 2023
Oral treatment with the all-d-peptide RD2 enhances cognition in aged beagle dogs - A model of sporadic Alzheimer's diseaseJanine Kutzsche, Sarah Schemmert, Tuyen Bujnicki, et al.
Scientific Reports|September 24, 2015
QIAD assay for quantitating a compound's efficacy in elimination of toxic Aβ oligomersOleksandr Brener, Tina Dunkelmann, Lothar Gremer, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cell Biology International|February 16, 2002
Production and characterization of Escherichia coli enterohemolysin and its effects on the structure of erythrocyte membranesDagmar Jürgens, Muhsin Ozel, Ntondo B Takaisi-Kikuni
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentDieter Willbold, Janine Kutzsche, Nicoleta Carmen Cosma, et al.
Molecules (Basel, Switzerland)|October 11, 2017
Large-Scale Oral Treatment Study with the Four Most Promising D3-Derivatives for the Treatment of Alzheimer's DiseaseJanine Kutzsche, Sarah Schemmert, Markus Tusche, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 27, 2020
Safety and pharmacokinetics of the orally available antiprionic compound PRI-002: A single and multiple ascending dose phase I studyJanine Kutzsche, Dagmar Jürgens, Antje Willuweit, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentDagmar Jürgens, Gerhard Tischler, Alexander Brener, et al.
British Journal of Pharmacology|December 29, 2023
An orally available Ca<sub>v</sub>2.2 calcium channel inhibitor for the treatment of neuropathic painJanine Kutzsche, Gustavo A Guzman, Antje Willuweit, et al.
Scientific Reports|November 28, 2017
The Aβ oligomer eliminating D-enantiomeric peptide RD2 improves cognition without changing plaque pathologyThomas van Groen, Sarah Schemmert, Oleksandr Brener, et al.
Neuropeptides|December 24, 2017
Aβ oligomer eliminating compounds interfere successfully with pEAβ(3-42) induced motor neurodegenerative phenotype in transgenic miceTina Dunkelmann, Kerstin Teichmann, Tamar Ziehm, et al.
Heliyon|August 23, 2023
Oral treatment with the all-d-peptide RD2 enhances cognition in aged beagle dogs - A model of sporadic Alzheimer's diseaseJanine Kutzsche, Sarah Schemmert, Tuyen Bujnicki, et al.
Scientific Reports|September 24, 2015
QIAD assay for quantitating a compound's efficacy in elimination of toxic Aβ oligomersOleksandr Brener, Tina Dunkelmann, Lothar Gremer, et al.
Pageof 1